SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-076725
Filing Date
2023-06-30
Accepted
2023-06-30 08:42:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2320299d2_424b5.htm 424B5 801042
2 GRAPHIC tm2320299d2_424b5img01.jpg GRAPHIC 7035
3 GRAPHIC tm2320299d2_424b5img02.jpg GRAPHIC 11483
  Complete submission text file 0001104659-23-076725.txt   828113
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254980 | Film No.: 231059660
SIC: 2834 Pharmaceutical Preparations